SUPPORTIVE THERAPY vs FAMILY THERAPY
Quality of life ‐ not reported · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Findings
What do systematic reviews say?
54 questions · 54 findings · 29 reviews
No studies found 48 · 88.9%GRADE not reported 6 · 11.1%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Dinutuximab‐containing immunotherapy vs usual care
Health‐related quality of life ‐ not reported · People with high‐risk neuroblastoma pre‐treated with autologous haematopoietic stem cell transplantation
The review found no eligible studies for this question.
1 finding from 1 review
- Anti‐GD2 antibody‐containing immunotherapy postconsolidation therapy for people with high‐risk neuroblastoma treated… 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Phytotherapy vs Another topical agent or placebo
Quality of life ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Neoadjuvant immunotherapy (high dose interferon) plus chemotherapy vs neoadjuvant chemotherapy
Quality of life ‐ not reported · stage III and IV cutaneous melanoma
The review found no eligible studies for this question.
1 finding from 1 review
- Neoadjuvant treatment for stage III and IV cutaneous melanoma 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Summary of findings table ‐ Platinum‐resistant recurrent EOC: PARPi monotherapy vs chemotherapy alone
Quality of Life ‐ not reported · recurrent platinum‐resistant EOC
The review found no eligible studies for this question.
1 finding from 1 review
- Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer 2022 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Summary of findings table ‐ Platinum‐sensitive recurrent EOC: PARPi with chemotherapy vs chemotherapy alone
Quality of Life ‐ not reported · platinum‐sensitive recurrent EOC
The review found no eligible studies for this question.
1 finding from 1 review
- Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer 2022 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Anti‐CD52 mAb maintenance therapy vs observation
Health‐related quality of life ‐ not reported · people with chronic lymphocytic leukaemia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Puvatherapy vs placebo or no treatment
Proportion of participants with at least 50% improvement in their quality of life ‐ not reported · chronic palmoplantar pustulosis
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Transrectal thermotherapy vs medical treatment
Quality of life ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2018 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Summary of findings table ‐ Contact immunotherapy (diphencyprone) + hair growth stimulants (minoxidil) vs contact immunotherapy (diphencyprone)
Health‐related quality of life ‐ not reported · adults with alopecia areata
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Retinoic acid post‐consolidation therapy vs no further treatment
Health‐related quality of life ‐ not reported · high‐risk neuroblastoma patients treated with autologous HSCT
The review found no eligible studies for this question.
1 finding from 1 review
- Retinoic acid postconsolidation therapy for high‐risk neuroblastoma patients treated with autologous haematopoietic… 2017 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Immunomodulatory drug maintenance therapy vs placebo/observation
Health‐related quality of life ‐ not reported · people with chronic lymphocytic leukaemia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Hyperbaric oxygen vs air breathing to enhance the effectiveness of radiotherapy
Quality of life ‐ not reported · People undergoing radiation therapy for head and neck cancer
The review found no eligible studies for this question.
1 finding from 1 review
- Hyperbaric oxygenation for tumour sensitisation to radiotherapy 2018 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Extracorporeal shockwave therapy vs control procedure
Quality of life ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2018 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Transrectal thermotherapy (add‐on) vs medical treatment
Quality of life ‐ not reported · participants with chronic prostatitis/chronic pelvic pain syndrome
The review found no eligible studies for this question.
1 finding from 1 review
- Non‐pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2018 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found
Etretinate with PUVA therapy as co‐intervention vs placebo with PUVA therapy
Proportion of participants with at least 50% improvement in their quality of life ‐ not reported · chronic palmoplantar pustulosis
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings table ‐ Other therapies (cryotherapy) vs other therapies (fractional CO2 laser)
Health‐related quality of life ‐ not reported · adults with alopecia areata
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings table ‐ Contact immunotherapy (diphencyprone or squaric acid dibutil ester) vs placebo
Health‐related quality of life ‐ not reported · adults with alopecia areata
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Summary of findings table ‐ Contact immunotherapy (diphencyprone or squaric acid dibutil ester) vs hair growth stimulants (minoxidil)
Health‐related quality of life ‐ not reported · adults with alopecia areata
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
Intervention not reported
Quality of life ‐ not reported · Adults with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem…
The review found no eligible studies for this question.
1 finding from 1 review
- Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated… 2024 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found